SIRT1-FOXOs activity regulates diabetic complications
MP Jalgaonkar, UM Parmar, YA Kulkarni… - Pharmacological …, 2022 - Elsevier
The prevalence of diabetes is continuously increasing in the recent decades. Persistent
hyperglycemia, hyperinsulinemia and the subsequent oxidative stress result in diabetic …
hyperglycemia, hyperinsulinemia and the subsequent oxidative stress result in diabetic …
Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: Novel opportunities for primary prevention
G Benincasa, E Coscioni, C Napoli - Biochemical Pharmacology, 2022 - Elsevier
One of the major challenges of cardiovascular primary prevention approach is the absence
of early biomarkers of endothelial dysfunction which may be useful for identifying at-risk …
of early biomarkers of endothelial dysfunction which may be useful for identifying at-risk …
Human sirtuin regulators: the “success” stories
The human sirtuins are a group of NAD+-dependent protein deacylases. They “erase” acyl
modifications from lysine residues in various cellular targets including histones, transcription …
modifications from lysine residues in various cellular targets including histones, transcription …
Recent advances in health benefits of stilbenoids
Biological targeting or molecular targeting is the main strategy in drug development and
disease prevention. However, the problem of “off-targets” cannot be neglected. Naturally …
disease prevention. However, the problem of “off-targets” cannot be neglected. Naturally …
Implications of resveratrol in obesity and insulin resistance: a state-of-the-art review
TM Barber, S Kabisch, HS Randeva, AFH Pfeiffer… - Nutrients, 2022 - mdpi.com
Background: Resveratrol is a polyphenol chemical that naturally occurs in many plant-based
dietary products, most notably, red wine. Discovered in 1939, widespread interest in the …
dietary products, most notably, red wine. Discovered in 1939, widespread interest in the …
A review on rhubarb-derived substances as modulators of cardiovascular risk factors—A special emphasis on anti-obesity action
O Liudvytska, J Kolodziejczyk-Czepas - Nutrients, 2022 - mdpi.com
The currently available anti-obesity therapies encounter many associated risks and side
effects often causing the ineffectiveness of treatment. Therefore, various plant-derived …
effects often causing the ineffectiveness of treatment. Therefore, various plant-derived …
Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells
Q Mu, M Najafi - International immunopharmacology, 2021 - Elsevier
Tumor resistance to therapy modalities is one of the major challenges to the eradication of
cancer cells and complete treatment. Tumor includes a wide range of cancer and non …
cancer cells and complete treatment. Tumor includes a wide range of cancer and non …
Natural radiosensitizers in radiotherapy: cancer treatment by combining ionizing radiation with resveratrol
D Komorowska, T Radzik, S Kalenik… - International Journal of …, 2022 - mdpi.com
Conventional cancer treatment is mainly based on the surgical removal of the tumor
followed by radiotherapy and/or chemotherapy. When surgical removal is not possible …
followed by radiotherapy and/or chemotherapy. When surgical removal is not possible …
The role of resveratrol administration in human obesity
LM Mongioì, S La Vignera, R Cannarella… - International journal of …, 2021 - mdpi.com
Obesity is a widespread disease that is associated with numerous and serious
comorbidities. These include metabolic syndrome, diabetes mellitus, cardiovascular …
comorbidities. These include metabolic syndrome, diabetes mellitus, cardiovascular …
Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice
N Shah, MA Abdalla, H Deshmukh… - Therapeutic …, 2021 - journals.sagepub.com
Diabetes mellitus (DM) is a chronic, progressive, and multifaceted illness resulting in
significant physical and psychological detriment to patients. As of 2019, 463 million people …
significant physical and psychological detriment to patients. As of 2019, 463 million people …